Skip to main content

and
  1. Article

    Open Access

    Imatinib use for gastrointestinal stromal tumors among older patients in Japan and Taiwan

    Tyrosine kinase inhibitors (TKIs) improve the prognosis of patients with gastrointestinal stromal tumors (GISTs). We conducted a retrospective cohort study using cancer registries linked with health utilizatio...

    Yuichi Ichinose, Yi-Hsin Yang, Hui-Jen Tsai, Ru-Yu Huang in Scientific Reports (2022)

  2. Article

    Open Access

    Survival outcomes of management in metastatic gastric adenocarcinoma patients

    Chemotherapy is generally considered as the main treatment for metastatic gastric adenocarcinoma. The role of gastrectomy for metastatic gastric cancer without obvious symptoms is controversial. The objective ...

    Huang-Ming Hu, Hui-Jen Tsai, Hsiu-Ying Ku, Su-Shun Lo, Yan-Shen Shan in Scientific Reports (2021)

  3. Article

    Open Access

    No association between alcohol consumption and pancreatic cancer even among individuals genetically susceptible to the carcinogenicity of alcohol

    Inconsistent results have been reported for the association between alcohol use and pancreatic cancer, particularly at low levels of alcohol consumption. Individuals genetically susceptible to the carcinogenic...

    Yan-Shen Shan, Li-Tzong Chen, Chih-Hsing Wu, Yin-Fan Chang in Scientific Reports (2021)

  4. Article

    Open Access

    An updated analysis of the epidemiologic trends of neuroendocrine tumors in Taiwan

    The incidence of neuroendocrine tumors (NETs) has been increasing in recent decades. Previously, we reported the incidence and survival of NETs in Taiwan by analyzing the 1996–2008 data from the Taiwan Cancer ...

    Jeffrey S. Chang, Li-Tzong Chen, Yan-Shen Shan, Pei-Yi Chu in Scientific Reports (2021)

  5. Article

    Open Access

    Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors

    S-1, an oral pyrimidine fluoride-derived agent, is effective against various cancers. Sorafenib, an oral multikinase inhibitor, was found to prolong the survival of various cancers and enhance the cytotoxicity...

    Hui-Jen Tsai, Her-Shyong Shiah, Jang-Yang Chang, Wu-Chou Su in Scientific Reports (2021)

  6. Article

    Open Access

    Author Correction: The Impact of Liposomal Irinotecan on the Treatment of Advanced Pancreatic Adenocarcinoma: Real-World Experience in a Taiwanese Cohort

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    Yung-Yeh Su, Nai-Jung Chiang, Hui-Jen Tsai, Chia-Jui Yen in Scientific Reports (2020)

  7. Article

    Open Access

    The Impact of Liposomal Irinotecan on the Treatment of Advanced Pancreatic Adenocarcinoma: Real-World Experience in a Taiwanese Cohort

    Liposomal irinotecan plus 5-fluorouracil/leucovorin (nal-IRI + 5-FU/LV) has shown to provide survival benefits for patients with gemcitabine-refractory metastatic pancreatic ductal adenocarcinoma (PDAC) in NAP...

    Yung-Yeh Su, Nai-Jung Chiang, Hui-Jen Tsai, Chia-Jui Yen in Scientific Reports (2020)

  8. Article

    Open Access

    A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia Patients

    Exogenous arginine is required for growth in some argininosuccinate synthetase (ASS)-deficient cancers. Arginine deiminase (ADI) inhibits growth in various ASS-deficient cancers by depleting arginine. The effi...

    Hui-Jen Tsai, Shih Sheng Jiang, Wen-Chun Hung, Gautam Borthakur in Scientific Reports (2017)

  9. Article

    Open Access

    The oncometabolite R-2-hydroxyglutarate activates NF-κB-dependent tumor-promoting stromal niche for acute myeloid leukemia cells

    Mutations of isocitrate dehydrogenase 1 (IDH1) and IDH2 in acute myeloid leukemia (AML) cells produce the oncometabolite R-2-hydroxyglutarate (R-2HG) to induce epigenetic alteration and block hematopoietic differ...

    **g-Yi Chen, You-Syuan Lai, Hui-Jen Tsai, Cheng-Chin Kuo in Scientific Reports (2016)